129 related articles for article (PubMed ID: 23936819)
1. Ctla-4 expression and polymorphisms in lung tissue of patients with diagnosed non-small-cell lung cancer.
Antczak A; Pastuszak-Lewandoska D; Górski P; Domańska D; Migdalska-Sęk M; Czarnecka K; Nawrot E; Kordiak J; Brzeziańska E
Biomed Res Int; 2013; 2013():576486. PubMed ID: 23936819
[TBL] [Abstract][Full Text] [Related]
2. CTLA-4, CD28, and ICOS gene polymorphism associations with non-small-cell lung cancer.
Karabon L; Pawlak E; Tomkiewicz A; Jedynak A; Passowicz-Muszynska E; Zajda K; Jonkisz A; Jankowska R; Krzakowski M; Frydecka I
Hum Immunol; 2011 Oct; 72(10):947-54. PubMed ID: 21669243
[TBL] [Abstract][Full Text] [Related]
3. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm.
Abtahi S; Izadi Jahromi F; Dabbaghmanesh MH; Malekzadeh M; Ghaderi A
Endocrine; 2018 Oct; 62(1):159-165. PubMed ID: 30078171
[TBL] [Abstract][Full Text] [Related]
4. CTLA-4 +49A>G polymorphism is associated with advanced non-small cell lung cancer prognosis.
Song B; Liu Y; Liu J; Song X; Wang Z; Wang M; Zhu Y; Han J
Respiration; 2011; 82(5):439-44. PubMed ID: 21832820
[TBL] [Abstract][Full Text] [Related]
5. Analysis of cytotoxic T lymphocyte antigen-4 (CTLA-4) promoter -318C/T and +49A/G gene polymorphisms in Turkish patients with familial Mediterranean fever.
Gunesacar R; Erken E; Dinkci S
Cell Biochem Biophys; 2013 Mar; 65(2):181-6. PubMed ID: 22923220
[TBL] [Abstract][Full Text] [Related]
6. Association of CTLA-4 gene polymorphism with end-stage renal disease and renal allograft outcome.
Misra MK; Kapoor R; Pandey SK; Sharma RK; Agrawal S
J Interferon Cytokine Res; 2014 Mar; 34(3):148-61. PubMed ID: 24313821
[TBL] [Abstract][Full Text] [Related]
7. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
[TBL] [Abstract][Full Text] [Related]
8. Association of CTLA-4, TNF alpha and IL 10 polymorphisms with susceptibility to hepatocellular carcinoma.
Wang JJ; Wang ZB; Tan TC
Scand J Immunol; 2019 Dec; 90(6):e12819. PubMed ID: 31448426
[TBL] [Abstract][Full Text] [Related]
9. -318C/T polymorphism of the CTLA-4 gene is an independent risk factor for RBC alloimmunization among sickle cell disease patients.
Oliveira VB; Dezan MR; Gomes FCA; Menosi Gualandro SF; Krieger JE; Pereira AC; Marsiglia JD; Levi JE; Rocha V; Mendrone-Junior A; Sabino EC; Dinardo CL
Int J Immunogenet; 2017 Oct; 44(5):219-224. PubMed ID: 28815969
[TBL] [Abstract][Full Text] [Related]
10. CD28/CTLA-4/ICOS haplotypes confers susceptibility to Graves' disease and modulates clinical phenotype of disease.
Pawlak-Adamska E; Frydecka I; Bolanowski M; Tomkiewicz A; Jonkisz A; Karabon L; Partyka A; Nowak O; Szalinski M; Daroszewski J
Endocrine; 2017 Jan; 55(1):186-199. PubMed ID: 27638540
[TBL] [Abstract][Full Text] [Related]
11. Lack of association between CTLA-4 +49A/G and -318C/T polymorphisms and Behçet's disease risk: a meta-analysis.
Zhang YJ; Xu WD; Duan ZH; Liu SS; Pan HF; Ye DQ
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S46-50. PubMed ID: 23010350
[TBL] [Abstract][Full Text] [Related]
12. Association of CTLA-4 and CD28 Gene Polymorphisms with Type 1 Diabetes in South Indian Population.
Gunavathy N; Asirvatham A; Chitra A; Jayalakshmi M
Immunol Invest; 2019 Aug; 48(6):659-671. PubMed ID: 31094250
[TBL] [Abstract][Full Text] [Related]
13. Investigation of CTLA-4 and CD86 gene polymorphisms in Iranian patients with brucellosis infection.
Eskandari-Nasab E; Moghadampour M; Najibi H; Hadadi-Fishani M
Microbiol Immunol; 2014 Feb; 58(2):135-41. PubMed ID: 24298899
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T-lymphocyte antigen-4 genetic variants and risk of Ewing's sarcoma.
Feng D; Yang X; Li S; Liu T; Wu Z; Song Y; Wang J; Gao W; Huang Q; Huang W; Zheng W; Xiao J
Genet Test Mol Biomarkers; 2013 Jun; 17(6):458-63. PubMed ID: 23480667
[TBL] [Abstract][Full Text] [Related]
15. Association of CTLA-4 gene polymorphisms -318C/T and +49A/G and Hashimoto's thyroidits in Zahedan, Iran.
Narooie-Nejad M; Taji O; Kordi Tamandani DM; Kaykhaei MA
Biomed Rep; 2017 Jan; 6(1):108-112. PubMed ID: 28123718
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic T-lymphocyte antigen-4 polymorphisms and susceptibility to osteosarcoma.
Liu Y; He Z; Feng D; Shi G; Gao R; Wu X; Song W; Yuan W
DNA Cell Biol; 2011 Dec; 30(12):1051-5. PubMed ID: 21612409
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and acute rejection risk in transplant recipients.
Zhu CL; Huang Q; Liu CH; Xie F
Mol Biol Rep; 2012 Sep; 39(9):8701-8. PubMed ID: 22711308
[TBL] [Abstract][Full Text] [Related]
18. CTLA-4 and CD28 genes' polymorphisms and renal cell carcinoma susceptibility in the Polish population--a prospective study.
Tupikowski K; Partyka A; Kolodziej A; Dembowski J; Debinski P; Halon A; Zdrojowy R; Frydecka I; Karabon L
Tissue Antigens; 2015 Nov; 86(5):353-61. PubMed ID: 26403483
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the cytotoxic T-lymphocyte antigen 4 gene and cancer risk: a meta-analysis.
Zhang Y; Zhang J; Deng Y; Tian C; Li X; Huang J; Fan H
Cancer; 2011 Sep; 117(18):4312-24. PubMed ID: 21387262
[TBL] [Abstract][Full Text] [Related]
20. Genetic variations in cytotoxic T-lymphocyte antigen-4 and susceptibility to cervical cancer.
Xiong YH; He L; Fei J
Int Immunopharmacol; 2014 Jan; 18(1):71-6. PubMed ID: 24201079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
